INVESTIGATIONS ON THE OCCURRENCE OF Rh SUBSTANCES IN AMNIOTIC FLUID.

Area of Science:

• Immunology
• Obstetrics
• Genetics

Background:

• Rh substances are detectable in amniotic fluid.
• The presence and detection of Rh substances in amniotic fluid are influenced by various factors, including antisera suitability and secretor status.
• Previous research has established the existence of Rh substances in amniotic fluid, but their precise determinants and implications require further clarification.

Purpose of the Study:

• To investigate the factors influencing the presence and detection of Rh substances in amniotic fluid.
• To determine the relationship between the Rh type of the fetus and the mother concerning Rh substances in amniotic fluid.
• To explore the association between Rh secretor status and the presence of Rh substances in amniotic fluid.

Main Methods:

• Analysis of Rh substances in amniotic fluid samples.
• Selection and utilization of specific anti-Rh sera for detection.
• Correlation of findings with fetal and maternal Rh types and secretor status.

Main Results:

• Rh substances are found in amniotic fluid, with detection success dependent on careful antisera selection and quantitative assessment.
• The baby's Rh type, not the mother's, dictates the presence of Rh substances in amniotic fluid.
• Rh secretor and non-secretor individuals exist, with secretors being more common; Rh substance secretion into amniotic fluid is independent of blood group substance secretion.
• Most Rh-positive amniotic fluids contain both Rh(1) and Rh(2) substances, though pure Rh(1) or Rh(2) types can occur.
• Amniotic fluid samples from three cases of erythroblastosis (Rh-negative mother, Rh-positive baby) did not show detectable Rh substances.

Conclusions:

• The presence of Rh substances in amniotic fluid is primarily linked to the fetal Rh type.
• Effective detection of Rh substances in amniotic fluid necessitates appropriate antisera and consideration of secretor phenotypes.
• Further research is warranted to understand the implications of Rh substances in amniotic fluid, particularly in cases of Rh incompatibility and erythroblastosis fetalis.